Cargando…
Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose
BACKGROUND: Coronavirus disease 2109 (COVID-19) vaccines have recently been approved to curb the global pandemic. The risk of allergic reactions to the vaccine polyethylene glycol (PEG) component has raised significant public concern. Desensitization is suggested in cases of vaccine related hypersen...
Autores principales: | AlMuhizi, Faisal, Ton-Leclerc, Shaonie, Fein, Michael, Tsoukas, Christos, Garvey, Lene Heise, Lee, Derek, Ben-Shoshan, Moshe, Isabwe, Ghislaine A. C., Copaescu, Ana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974752/ https://www.ncbi.nlm.nih.gov/pubmed/35386647 http://dx.doi.org/10.3389/falgy.2022.825164 |
Ejemplares similares
-
Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization
por: AlOtaibi, Ibtihal, et al.
Publicado: (2023) -
Tolerance of the mRNA COVID-19 vaccines in patients with reported taxane reactions
por: Alenazy, Leila A., et al.
Publicado: (2022) -
REVISITING HYPERSENSITIVITY REACTIONS TO THE MRNA COVID-19 VACCINE: TOLERANCE AFTER PREVIOUS HISTORY OF ANAPHYLAXIS
por: AlOtaibi, I., et al.
Publicado: (2022) -
Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience
por: ALMuhizi, Faisal, et al.
Publicado: (2022) -
Reply to “Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines”
por: Picard, Matthieu, et al.
Publicado: (2022)